Drug interactions
Linagliptin-metformin + Medroxyprogesterone
Severity: Minor
Linagliptin-metformin and Medroxyprogesterone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Progestins such as medroxyprogesterone can modestly impair glucose tolerance and may reduce the glucose-lowering effect of antidiabetic therapy. The effect is usually small and clinically relevant mainly with long-term or high-dose use.
What this interaction means in plain words
Linagliptin-metformin and Medroxyprogesterone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Linagliptin-metformin belongs to Endocrine; Medroxyprogesterone belongs to Endocrine.
Why it happens
Progestogens may increase insulin resistance, producing pharmacodynamic antagonism of antidiabetic effects.
What to do
Monitor fasting glucose and HbA1c when starting or stopping medroxyprogesterone, and adjust antidiabetic therapy if control worsens.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin-metformin and Medroxyprogesterone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Medroxyprogesterone
Frequently asked questions
Can I take Linagliptin-metformin with Medroxyprogesterone?
MediHelp rates the interaction as minor. Linagliptin-metformin and Medroxyprogesterone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Progestins such as medroxyprogesterone can modestly impair glucose tolerance and may reduce the glucose-lowering effect of antidiabetic therapy. The effect is usually small and clinically relevant mainly with long-term or high-dose use.
How serious is the interaction between Linagliptin-metformin and Medroxyprogesterone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor fasting glucose and HbA1c when starting or stopping medroxyprogesterone, and adjust antidiabetic therapy if control worsens.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
